Registration Is Now Open For Tribe Public's Webinar Event "Diabetes, Obesity, GLP-1, & The MODD-1 Opportunity" Featuring Modular Medical CEO On Wednesday, September 11, 2024

Rhea-AI Summary

Modular Medical (Nasdaq: MODD) has announced a webinar event titled 'Diabetes, Obesity, GLP-1, & The MODD-1 Opportunity' featuring CEO Jeb Besser. The event, scheduled for September 11, 2024, will address critical health issues and market opportunities. Key points include:

• Over 3 million people in the US use daily insulin for diabetes management
• Only 20% of insulin-dependent patients currently use insulin pumps
• Obesity is linked to 30-53% of new diabetes cases annually in the US
• About 50% of patients prescribed GLP-1 drugs for weight loss discontinue within 12 weeks

The webinar aims to discuss these trends and Modular Medical's potential in the insulin pump technology market.

Positive

• Modular Medical is addressing a large market with over 3 million daily insulin users in the US
• Low insulin pump adoption rate (20%) suggests significant growth potential for MODD's technology
• Webinar event may increase investor awareness and interest in MODD stock

Negative

• High discontinuation rate of GLP-1 drugs may indicate challenges in long-term treatment adherence
• Competitive market with established players in insulin pump technology

• Meet with Modular Medical CEO, Jeb Besser

• There are more than 3 million individuals who use daily insulin to help with the care of Diabetes in the US.100% of patient population require daily insulin injection. Only 20% currently use an insulin pump.

• Obesity is linked to 30% to 53% of new diabetes cases in the U.S. every year, per research in the Journal of the American Heart Association

• About half of all patients prescribed a GLP-1 drug for weight loss discontinued after the first 12 weeks, with approximately 30% discontinuing in the first four weeks

SAN DIEGO, CA / ACCESSWIRE / September 9, 2024 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), a development-stage, insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, today announced that Jeb Besser, CEO, will present at Tribe Public's Webinar Presentation and Q&A Event titled "Diabetes, Obesity, GLP-1, & The MODD-1 Opportunity." The event is scheduled to begin at 8:30am pacific/11:30am eastern on Wednesday, September 11, 2024. To register to join the complimentary event, please visit the Tribe Public LLC at MODD-GLP-1.TribePublic.com.

Once registered, participants may begin forwarding their questions for the CEO to Tribe Public at research@tribepublic.com or share their questions via the ZOOM chat feature during the event. Tribe Public's Managing Member, John F. Heerdink, Jr., will host the event and relay all questions to management.

About Modular Medical

Modular Medical, Inc. (Nasdaq: MODD) is a medical device company that will launch the next generation of insulin delivery technology. Using its patented technologies, the Company seeks to eliminate the tradeoff between complexity and clinical efficacy, thereby making top quality insulin delivery both affordable and simple to learn. The Company's mission is to improve access to the highest standard of glycemic control for people with diabetes, taking it beyond "superusers" and providing diabetes care for the rest of us.

Modular Medical was founded by Paul DiPerna, a seasoned medical device professional and microfluidics engineer. Prior to founding MODD, Mr. DiPerna was the founder (in 2005) of Tandem Diabetes and invented and designed its t:slim insulin pump. More information is available at https://modular-medical.com.

ABOUT TRIBE PUBLIC LLC

Tribe Public LLC is a San Francisco, CA based organization that hosts complimentary worldwide webinar & meeting events in the U.S. Tribe's complimentary events focus on issues that the Tribe members care about with an emphasis on hosting management teams from publicly traded companies from all sectors & financial organizations that are seeking to increase awareness of their products, progress and plans. Tribe members primarily include Family Offices, Portfolio Managers, Registered Investment Advisors, Accredited Investors, Sell Side Analysts, and members of media. Tribe members are encouraged to express their interest in speakers they care about and want to learn from at the Tribe Public website via the Tribe's FREE "Wish List" process. Visit Tribe Public's Website to learn more: http://www.tribepublic.com/

CONTACT:

Jeb Besser
Chief Executive Officer
Modular Medical, Inc.
+1 (617) 399-1741
IR@modular-medical.com

SOURCE: Modular Medical, Inc.

View the original press release on accesswire.com

FAQ

When is Modular Medical's (MODD) webinar event scheduled?

Modular Medical's (MODD) webinar event is scheduled for Wednesday, September 11, 2024, at 8:30am Pacific/11:30am Eastern time.

What is the title of Modular Medical's (MODD) upcoming webinar?

The title of Modular Medical's (MODD) upcoming webinar is 'Diabetes, Obesity, GLP-1, & The MODD-1 Opportunity'.

What percentage of insulin-dependent patients currently use insulin pumps, according to Modular Medical (MODD)?

According to Modular Medical (MODD), only 20% of insulin-dependent patients currently use insulin pumps.

How many people in the US use daily insulin for diabetes management, as mentioned in Modular Medical's (MODD) press release?

According to Modular Medical's (MODD) press release, over 3 million people in the US use daily insulin for diabetes management.